Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

rare pediatric disease designation

POPULAR ARTICLES

Cellectar’s CLR 131 Receives FDA Orphan Drug Designation for the Treatment of Pediatric Osteosarcoma

FDA Grants Rare Pediatric Disease Designation to Cellectar Biosciences’ CLR 131 for the Treatment of Osteosarcoma

Krystal Biotechs’ KB105 Receives Rare Pediatric Disease Designation from the FDA to Treat Patients with TGM-1-deficient Autosomal Recessive Congenital Ichthyosis

LATEST ARTICLES

pharmaceutical investing

FDA Grants Rare Pediatric Disease Designation to A4250; Albireo Eligible to Apply for Priority Review Voucher

Latest News

Lexaria Updates Financial Position

Homeland Provides Exploration and Corporate Update

Nevada's Oxide Gold Districts Are Being Redrilled for a Second Metal

QIMC Launches Expanded 2026 Ontario Natural Hydrogen Program in the Témiscamingue Graben

NevGold Intercepts 1.06 g/t Oxide Au Over 42.7 Meters Outside of 2026 MRE Pit-shell; Mineralization Also Expanded Inside Pit-Shell With 5.00 g/t Oxide Au Over 3.0 Meters Within 1.23 g/t Oxide Au Over 27.4 Meters at Limo Butte, Nevada

Outlook Reports world

Precious Metals
- Gold
- Silver
Battery Metals
Energy
- Uranium
- Oil and Gas

Base Metals
Critical Metals
- Rare Earths
Industrial Metals
Agriculture

- Cleantech
- Emerging Tech

- Biotech
- Cannabis

- Psychedelics
- Pharmaceuticals

Featured Stocks

Zentek

ZEN:CC

Hercules Metals

BIG:CC

Baru Gold

BARU:CC

Emperor Metals

AUOZ:CC

Fortune Bay

Fortune Bay (FOR:CC)

FOR:CC

Solstice Gold

SGC:CC

More featured stocks

Browse Companies

Precious Metals
Battery Metals
Energy

Base Metals
Critical Metals

MARKETS

COMMODITIES

CURRENCIES